% 51.4% 58.9% Remark: * EBITDA = Earnings before Interest, Taxes, Depreciation and Amortization - Non-operating income / (expense) ** Normalized net profit = Net profit – Unrealized gain / (loss) from FX
higher in borrowing and interest rate. 5. For the year 2018 there were other revenues of 3.97 million baht and gain on commodity swap of 44.44 million Baht . Loss from exchange rate was 0.083 million Baht
commodity swap of 26.79 million Baht due to higher aluminium price. Gain from exchange rate was 9.55million Baht due to appreciation in Thai Baht during this year. 6. In conclusion, for the year 2017, the
project management 195.2 4.7 280.0 8.4 84.8 43.4 Dividend income - - 0.3 - 0.3 100.0 Gain from transfer of right for land purchase and sale agreement 312.0 7.5 - - (312.0) (100.0) Gain on disposals of
173,892 91.30 Income from Sevice 60,291 107,527 (47,236) (43.93) Cost of Sale of Goods (244,903) (151,506) 93,397 (61.65) Cost of Service (34,589) (59,328) (24,739) 41.70 Gross Profit 145,153 87,155 57,998
performance of the listed companies. Whereas in the second quarter 2019, The Company had gain on sale of equity securities. The Company recognized share of profit from associates of Baht 24.06 million in this
6.1% 279.4 7.2% Gross Profit 68.0 56.6 20.1% 63.3 7.4% Profit (Loss) from the operation 3.3 (26.0) 112.7% (26.4) 112.5% Gain (Loss) from temporary investment (6.3) (21.7) 71.0% 1.5 (520%) Profit (Loss
subsidiaries for the three- month period ended March 31, 2018 and would like to clarify Q1/2018 operating results as follows: The consolidated net profit attributable to equity owners of the Company for the
the gain on disposal of investment in Ngam-Ngum 3 project for THB 14.56 million compared to THB 95.15 million in 2017. ▪ The THB 83.64-million-reversal of doubtful debt recorded in 2018 comes mainly
to Baht 19.41 million or 15.91% The other income went up 22.10% amount to Baht 18.15 million due to gain on sales of medical equipment amount to Baht 9.17 million. 2. The cost of medical treatments